JP2025514636A5 - - Google Patents
Info
- Publication number
- JP2025514636A5 JP2025514636A5 JP2024558241A JP2024558241A JP2025514636A5 JP 2025514636 A5 JP2025514636 A5 JP 2025514636A5 JP 2024558241 A JP2024558241 A JP 2024558241A JP 2024558241 A JP2024558241 A JP 2024558241A JP 2025514636 A5 JP2025514636 A5 JP 2025514636A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- seq
- antigen
- binding fragment
- sequence shown
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210343364.4 | 2022-04-02 | ||
| CN202210345737 | 2022-04-02 | ||
| CN202210345737.1 | 2022-04-02 | ||
| CN202210343364 | 2022-04-02 | ||
| PCT/CN2023/085460 WO2023186092A1 (zh) | 2022-04-02 | 2023-03-31 | 针对c-Met的单克隆抗体以及双特异性抗体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025514636A JP2025514636A (ja) | 2025-05-09 |
| JP2025514636A5 true JP2025514636A5 (cg-RX-API-DMAC10.html) | 2025-08-07 |
Family
ID=88199447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024558241A Pending JP2025514636A (ja) | 2022-04-02 | 2023-03-31 | ｃ－Ｍｅｔに対するモノクローナル抗体及び二重特異性抗体 |
Country Status (11)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025146619A1 (ko) * | 2024-01-02 | 2025-07-10 | 주식회사 종근당 | 항 c-met 항체를 포함하는 항암 조합물 |
| WO2025185602A1 (en) * | 2024-03-05 | 2025-09-12 | Hansoh Bio Llc | Immunoconjugates and pharmaceutical uses thereof |
| WO2025190404A1 (zh) * | 2024-03-14 | 2025-09-18 | 珠海普米斯生物科技有限公司 | 双特异性抗体、抗体药物偶联物及其应用 |
| WO2025247330A1 (zh) * | 2024-05-31 | 2025-12-04 | 江苏先声生物制药有限公司 | 抗EGFR×cMet双特异性抗体的药物偶联物及其用途 |
| CN121868507A (zh) * | 2024-10-16 | 2026-04-17 | 上海安领科生物医药有限公司 | 抗EGFR和cMET双特异性抗体的抗体药物偶联物 |
| WO2026145588A1 (en) * | 2024-12-31 | 2026-07-09 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Use of egfr/c-met bispecific binding protein |
| CN121045385B (zh) * | 2025-11-03 | 2026-02-10 | 广州安必平医药科技股份有限公司 | 一种抗c-met蛋白单克隆抗体及其相关产品和用途 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| KR100945108B1 (ko) | 2001-06-13 | 2010-03-02 | 젠맵 에이/에스 | 표피 성장 인자 수용체 (ｅｇｆｒ)에 대한 인간모노클로날 항체 |
| HN2004000285A (es) * | 2003-08-04 | 2006-04-27 | Pfizer Prod Inc | ANTICUERPOS DIRIGIDOS A c-MET |
| ME01803B (me) * | 2004-08-05 | 2010-12-31 | Genentech Inc | Humanizovani anti-cmet antagonisti |
| BRPI0709917A2 (pt) * | 2006-03-30 | 2011-07-05 | Novartis Ag | composições e métodos de uso para anticorpos de c-met |
| SG188802A1 (en) * | 2008-03-06 | 2013-04-30 | Genentech Inc | Combination therapy with c-met and egfr antagonists |
| EP3904391B1 (en) | 2010-03-10 | 2024-07-10 | Genmab A/S | Monoclonal antibodies against c-met |
| KR20130037153A (ko) * | 2011-10-05 | 2013-04-15 | 삼성전자주식회사 | 항 ｃ-Ｍｅｔ 항체 및 그의 용도 |
| KR101844479B1 (ko) * | 2011-11-17 | 2018-04-03 | 삼성전자주식회사 | 항 ｃ-Ｍｅｔ 항체 및 그의 용도 |
| US20170275367A1 (en) * | 2012-11-21 | 2017-09-28 | Janssen Biotech, Inc. | Bispecific EGFR/C-Met Antibodies |
| TW201609805A (zh) * | 2013-12-23 | 2016-03-16 | 美國禮來大藥廠 | 結合ｅｇｆｒ及ｍｅｔ之多功能抗體 |
| EP3630844A4 (en) * | 2017-05-30 | 2021-03-03 | Chong Kun Dang Pharmaceutical Corp. | NOVEL ANTI-C-MET ANTIBODY AND USE OF IT |
| AU2020357944A1 (en) | 2019-09-30 | 2022-03-31 | Adimab, Llc | CH1 domain variants engineered for preferential light chain pairing and multispecific antibodies comprising the same |
-
2023
- 2023-03-31 CN CN202380031276.3A patent/CN119013296A/zh active Pending
- 2023-03-31 IL IL315910A patent/IL315910A/en unknown
- 2023-03-31 EP EP23778456.6A patent/EP4506363A4/en active Pending
- 2023-03-31 AU AU2023247654A patent/AU2023247654A1/en active Pending
- 2023-03-31 WO PCT/CN2023/085460 patent/WO2023186092A1/zh not_active Ceased
- 2023-03-31 JP JP2024558241A patent/JP2025514636A/ja active Pending
- 2023-03-31 KR KR1020247036568A patent/KR20240168447A/ko active Pending
- 2023-03-31 US US18/852,602 patent/US20250223366A1/en active Pending
-
2024
- 2024-09-30 MX MX2024012143A patent/MX2024012143A/es unknown
- 2024-10-02 CL CL2024002974A patent/CL2024002974A1/es unknown
- 2024-10-31 ZA ZA2024/08262A patent/ZA202408262B/en unknown